Lumos Diagnostics Holdings Limited

ASX (AUD): Lumos Diagnostics Holdings Limited (LDX)

Last Price

0.03

Today's Change

-0.003 (9.09%)

Day's Change

0.03 - 0.032

Trading Volume

2,506,205

Overview

Market Cap

24 Million

Shares Outstanding

820 Million

Avg Volume

2,897,221

Avg Price (50 Days)

0.04

Avg Price (200 Days)

0.05

PE Ratio

-1.00

EPS

-0.03

Earnings Announcement

24-Feb-2025

Previous Close

0.03

Open

0.03

Day's Range

0.03 - 0.032

Year Range

0.028 - 0.1075

Trading Volume

2,506,205

Price Change Highlight

1 Day Change

-9.09%

5 Day Change

-9.09%

1 Month Change

-34.78%

3 Month Change

-22.02%

6 Month Change

-34.75%

Ytd Change

-60.00%

1 Year Change

-54.33%

3 Year Change

-95.86%

5 Year Change

-97.35%

10 Year Change

-97.35%

Max Change

-97.35%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment